202 related articles for article (PubMed ID: 22381424)
1. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet medications: old and emerging therapies.
Stone WM; Naidu SG; Chapital A; Money SR
Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
[TBL] [Abstract][Full Text] [Related]
3. Monitoring oral antiplatelet therapy: is it justified?
Ang L; Mahmud E
Ther Adv Cardiovasc Dis; 2008 Dec; 2(6):485-96. PubMed ID: 19124443
[TBL] [Abstract][Full Text] [Related]
4. Thienopyridines in cardiovascular disease: focus on clopidogrel resistance.
Siller-Matula J; Schrör K; Wojta J; Huber K
Thromb Haemost; 2007 Mar; 97(3):385-93. PubMed ID: 17334505
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet agents in acute coronary syndromes.
Sakhuja R; Yeh RW; Bhatt DL
Curr Probl Cardiol; 2010 Mar; 35(3):123-70. PubMed ID: 20152547
[TBL] [Abstract][Full Text] [Related]
6. Platelet perturbations in diabetes: implications for cardiovascular disease risk and treatment.
Mathewkutty S; McGuire DK
Expert Rev Cardiovasc Ther; 2009 May; 7(5):541-9. PubMed ID: 19419262
[TBL] [Abstract][Full Text] [Related]
7. The use of antiplatelet agents in cardiac disease.
Tepper D; Ip RJ; Ip JH
Manag Care Interface; 2000 May; 13(5):76-8. PubMed ID: 11067401
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of platelet activation-inhibitory drugs.
Rao GH; Rao AT
Indian J Physiol Pharmacol; 1994 Apr; 38(2):69-84. PubMed ID: 8063366
[TBL] [Abstract][Full Text] [Related]
9. The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?
Zhou RH; Frishman WH
Cardiol Rev; 2010; 18(4):198-203. PubMed ID: 20539103
[TBL] [Abstract][Full Text] [Related]
10. [Thrombocyte inhibitors in cardiovascular therapy].
Lüscher TF; Pfisterer M
Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1132-41. PubMed ID: 2218249
[TBL] [Abstract][Full Text] [Related]
11. The genetics of antiplatelet drug resistance.
Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
[TBL] [Abstract][Full Text] [Related]
12. Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy.
Christie DJ; Kottke-Marchant K; Gorman RT
Platelets; 2008 Mar; 19(2):104-10. PubMed ID: 17852773
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet agents: current drugs and future trends.
Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
[TBL] [Abstract][Full Text] [Related]
14. Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.
Patti G; De Caterina R; Abbate R; Andreotti F; Biasucci LM; Calabrò P; Cioni G; Davì G; Di Sciascio G; Golia E; Golino P; Malatesta G; Mangiacapra F; Marcucci R; Nusca A; Parato VM; Pengo V; Prisco D; Pulcinelli F; Renda G; Ricottini E; Ruggieri B; Santilli F; Sofi F; Zimarino M;
Eur Heart J; 2014 Sep; 35(33):2213-23b. PubMed ID: 25024407
[TBL] [Abstract][Full Text] [Related]
15. Current strategies in antiplatelet therapy--does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?
Geisler T; Gawaz M; Steinhubl SR; Bhatt DL; Storey RF; Flather M
Pharmacol Ther; 2010 Aug; 127(2):95-107. PubMed ID: 20570595
[TBL] [Abstract][Full Text] [Related]
16. Should we monitor platelet function during antiplatelet therapy?
Hjemdahl P
Heart; 2008 Jun; 94(6):685-7. PubMed ID: 18480343
[No Abstract] [Full Text] [Related]
17. Platelet biology and implications for antiplatelet therapy in atherothrombotic disease.
Montalescot G
Clin Appl Thromb Hemost; 2011 Aug; 17(4):371-80. PubMed ID: 20566574
[TBL] [Abstract][Full Text] [Related]
18. Update on aspirin in the treatment and prevention of cardiovascular disease.
Hennekens CH
Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
[TBL] [Abstract][Full Text] [Related]
19. Platelet monitoring for PCI: is it really necessary?
Tantry US; Gurbel PA
Hamostaseologie; 2009 Nov; 29(4):368-75. PubMed ID: 19882080
[TBL] [Abstract][Full Text] [Related]
20. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
Price MJ
Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
